Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

Authors: James Chih-Hsin Yang, Martin Schuler, Sanjay Popat, Satoru Miura, Keunchil Park, Antonio Passaro, Filippo De Marinis, Flavio Solca, Angela Märten, Edward S. Kim

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: afatinib, non-small-cell lung cancer, uncommon EGFR mutations, compound mutations, EGFR exon 20 insertions, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.834704/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/06285341cf024f7fb6cee27c5cc600a1

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

Authors: Sabine Zöchbauer-Müller, Bettina Kaserer, Helmut Prosch, Agnieszka Cseh, Flavio Solca, Markus Johann Bauer, Leonhard Müllauer

Source: Frontiers in Oncology, Vol 10 (2021)

Subject Terms: afatinib, EGFR mutation, exon 20 insertion, H773dup, long-term response, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2020.593852/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/85042a3ff8b84b48ba1aec215e208ab7

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

Authors: Alexandra Canonici, Alacoque L. Browne, Mohamed F. K. Ibrahim, Kevin P. Fanning, Sandra Roche, Neil T. Conlon, Fiona O’Neill, Justine Meiller, Mattia Cremona, Clare Morgan, Bryan T. Hennessy, Alex J. Eustace, Flavio Solca, Norma O’Donovan, John Crown

Source: Therapeutic Advances in Medical Oncology, Vol 12 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1758-8359

Access URL: https://doaj.org/article/30ed8d6b4bc948429c56a9912d216c9d

Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates

Authors: Wolfgang Lilleby, Flavio Solca, Kathrine Røe

Source: Oncology Reviews, Vol 5, Iss 2 (2011)

Subject Terms: Prostate cancer - EGF - HER2 - Radiotherapy - Theragnostics - Theragates, Other systems of medicine, RZ201-999, Internal medicine, RC31-1245

File Description: electronic resource

Relation: http://www.oncologyreviews.org/index.php/or/article/view/25; https://doaj.org/toc/1970-5557; https://doaj.org/toc/1970-5565

Access URL: https://doaj.org/article/a30b66d37dc14dcab223356653e97a56

Combination of EGFR/HER2 Tyrosine Kinase Inhibition by BIBW 2992 and BIBW 2669 with Irradiation in FaDu Human Squamous Cell Carcinoma.

Authors: Christina Schütze, Annegret Dörfler, Daniel Zips, Sandra Hering, Flavio Solca

Source: Strahlentherapie und Onkologie; May2007, Vol. 183 Issue 5, p256-264, 9p

Subject Terms: CANCER, SQUAMOUS cell carcinoma, TUMOR growth, CELL proliferation

This result is not displayed to guests.
Login for full access.